Brandywine Global Investment Management’s Ironwood Pharmaceuticals IRWD Stock Holding History

Brandywine Global Investment Management’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-478,605	Closed	-$5.48M	–	721
2023 Q4	$5.48M	Buy	478,605 +2,046	+0.4%	+$20.2K	0.04%	376
2023 Q3	$4.59M	Sell	476,559 -5,429	-1%	-$53.2K	0.04%	387
2023 Q2	$5.13M	Buy	481,988 +227,937	+90%	+$2.45M	0.04%	373
2023 Q1	$2.67M	Buy	+254,051	New	+$2.85M	0.02%	506
2022 Q4	–	Sell	-206,221	Closed	-$2.14M	–	754
2022 Q3	$2.14M	Sell	206,221 -9,640	-4%	-$109K	0.02%	530
2022 Q2	$2.49M	Sell	215,861 -11,849	-5%	-$140K	0.02%	490
2022 Q1	$2.87M	Buy	227,710 +12,956	+6%	+$149K	0.02%	478
2021 Q4	$2.5M	Hold	214,754	–	–	0.02%	499
2021 Q3	$2.81M	Buy	+214,754	New	+$2.78M	0.02%	486

Other funds holding IRWD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Brandywine Global Investment Management's IRWD Position: Q1 2024 in Review

Brandywine Global Investment Management sold out of Ironwood Pharmaceuticals (IRWD) in Q1 2024, closing a stake of 478,605 shares — an estimated $5.48M sold.

Brandywine Global Investment Management first reported a position in IRWD in Q3 2021 and held it in 9 quarters. The position peaked at $5.48M in Q4 2023. 261 funds tracked by Wall St. Rank hold IRWD as of Q1 2024.

Brandywine Global Investment Management reported no remaining Ironwood Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Brandywine Global Investment Management sold 478,605 Ironwood Pharmaceuticals shares in Q1 2024, an estimated $5.48M.
Brandywine Global Investment Management first reported a position in Ironwood Pharmaceuticals in Q3 2021 and held it in 9 quarters.
Brandywine Global Investment Management's Ironwood Pharmaceuticals position peaked at $5.48M in Q4 2023.
261 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2024.

Based on Brandywine Global Investment Management's 13F filing for Q1 2024, filed 13 May 2024.